Exploiting innate immunity for cancer immunotherapy

M Yi, T Li, M Niu, Q Mei, B Zhao, Q Chu, Z Dai, K Wu - Molecular cancer, 2023 - Springer
Immunotherapies have revolutionized the treatment paradigms of various types of cancers.
However, most of these immunomodulatory strategies focus on harnessing adaptive …

Targeting cytokine and chemokine signaling pathways for cancer therapy

M Yi, T Li, M Niu, H Zhang, Y Wu, K Wu… - Signal transduction and …, 2024 - nature.com
Cytokines are critical in regulating immune responses and cellular behavior, playing dual
roles in both normal physiology and the pathology of diseases such as cancer. These …

Tumor‐tailored ionizable lipid nanoparticles facilitate IL‐12 circular RNA delivery for enhanced lung cancer immunotherapy

S Xu, Y Xu, NC Solek, J Chen, F Gong… - Advanced …, 2024 - Wiley Online Library
The advancement of message RNA (mRNA)‐based immunotherapies for cancer is highly
dependent on the effective delivery of RNA (Ribonucleic) payloads using ionizable lipid …

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

B Wang, J Pei, S Xu, J Liu, J Yu - Frontiers in immunology, 2023 - frontiersin.org
Since the successful application of messenger RNA (mRNA) vaccines in preventing COVID-
19, researchers have been striving to develop mRNA vaccines for clinical use, including …

mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

I Olivera, E Bolaños, J Gonzalez-Gomariz… - Cell Reports …, 2023 - cell.com
Summary Interleukin-12 (IL-12) gene transfer enhances the therapeutic potency of adoptive
T cell therapies. We previously reported that transient engineering of tumor-specific CD8 T …

Lipid-based nanosystems: the next generation of cancer immune therapy

Z Cheng, SF Fobian, E Gurrieri, M Amin… - Journal of Hematology & …, 2024 - Springer
Immunotherapy has become an important part of the oncotherapy arsenal. Its applicability in
various cancer types is impressive, as well as its use of endogenous mechanisms to achieve …

Synthetic macromolecular switches for precision control of therapeutic cell functions

AP Teixeira, M Fussenegger - Nature Reviews Bioengineering, 2024 - nature.com
Cells rely on complex molecular networks to perceive and process external and internal
signals into tailored responses. These cellular abilities can be augmented and modified by …

Cisplatin-induced pyroptosis enhances the efficacy of PD-L1 inhibitor in small-cell lung cancer via GSDME/IL12/CD4Tem axis

W Xuzhang, T Lu, W **, Y Yu, Z Li… - International …, 2024 - pmc.ncbi.nlm.nih.gov
The combination therapy of platinum-based chemotherapy and PD-L1 inhibitors but not the
single anti-PD-L1 therapy has significantly improved the prognosis of patients with small-cell …

In situ cocktail nanovaccine for cancer immunotherapy

M Liu, D **e, D Hu, R Zhang, Y Wang, L Tang… - Advanced …, 2023 - Wiley Online Library
In situ vaccination is a desirable strategy for cancer immunotherapy due to its convenience
and capacity to target tumor antigens. Here, an in situ nanovaccine based on a cationic …

Emerging mRNA technology for liver disease therapy

J Wang, Y Fang, Z Luo, J Wang, Y Zhao - ACS nano, 2024 - ACS Publications
Liver diseases have consistently posed substantial challenges to global health. It is crucial
to find innovative methods to effectively prevent and treat these diseases. In recent times …